Over recent months I have found myself increasingly drawn into the biology of signalling.

Not simply peptides themselves, but the much wider question of how cells, tissues, inflammatory mediators, mitochondria, growth factors, extracellular vesicles and regenerative pathways continuously communicate with one another and, perhaps more importantly, how those messages are interpreted within stressed, inflamed or ageing biological environments.

The deeper I explore regenerative medicine, exosomes, pigmentation disorders, inflammatory signalling and longevity biology, the more I find myself wondering whether the future of regenerative aesthetics may depend not simply upon increasing biological signalling, but upon understanding the coherence of the entire signalling ecosystem itself.

Some early thoughts below.

Over recent months I have found myself becoming increasingly fascinated by the biology of signalling.

Not simply peptides themselves, although peptides were probably the original starting point, but the much wider question of how the body communicates internally and how those messages are interpreted biologically within health, inflammation, ageing and disease.

The more I explore regenerative medicine, pigmentation disorders, extracellular vesicles, neuroimmune pathways and longevity biology, the more I find myself returning to one central thought: the body is less a machine and more a signalling ecosystem.

Medicine has historically tended to view disease structurally. An inflamed joint. Fibrosis. Pigmentation. Neurodegeneration. Hormonal decline. Yet one increasingly begins to wonder whether many of the visible pathological changes we eventually recognise clinically are often the downstream consequence of altered signalling environments that may have existed silently for years beforehand.

That possibility becomes particularly interesting when viewed through the lens of peptides, growth factors, secretomes and exosomes.

A synthetic laboratory-produced peptide is, in many respects, relatively “emotionless biology”. It is a defined signalling molecule designed to interact with specific receptors or pathways.

Secretomes and exosomal systems, however, are something rather different entirely. They are biologically sourced signalling environments potentially containing extracellular vesicles, proteins, peptides, growth factors, inflammatory mediators, metabolic signals and stress responses generated by living biological systems under specific environmental conditions.

I believe this raises some fascinating biological questions.

If the source biology producing those signalling molecules was stressed, inflamed, hypoxic, metabolically dysregulated, virally challenged, senescent or even pre-malignant, does some aspect of that biological “state” influence the downstream signalling package eventually delivered into recipient tissue?

I do not ask that question from a position of criticism towards regenerative medicine. Far from it. I suspect signalling biology and extracellular vesicle science may eventually become some of the most important areas within medicine and aesthetics over the coming decades. However, biology rarely behaves simplistically.

Cancer biology itself is increasingly teaching us that extracellular vesicles are not biologically trivial. Malignant and pre-malignant cells appear capable of releasing vesicles which may influence surrounding tissue behaviour, inflammatory tone, angiogenesis and immune evasion. That does not mean exosomes are inherently dangerous, but it probably does mean they deserve a degree of scientific respect beyond some of the simpler commercial narratives currently surrounding them.

The more I explore, the more I find myself repeatedly returning to three increasingly important biological questions.

Firstly, what was the physiological state of the source producing the complex signalling message in the first place?

Secondly, what biological environment and method of delivery is being used to introduce that signalling package into tissue?

And thirdly, what is the physiological state of the recipient tissue attempting to interpret and respond to that communication?

Because all three environments may matter enormously.

The source biology may have been stressed, inflamed, senescent, hypoxic, metabolically dysregulated or exposed to inflammatory signalling long before any secretome or extracellular vesicle package was harvested.

The delivery environment itself may involve acute tissue injury, inflammatory activation, vascular permeability, oxidative stress and wound-healing cascades, particularly where procedures such as microneedling, fractional injury or energy-based treatments are involved.

And finally, the recipient tissue may already be biologically reactive, chronically inflamed, vascularly unstable, oxidatively stressed, hormonally influenced, immunologically distracted or metabolically compromised before the signalling message even arrives.

Pigmentation biology provides an interesting example of this complexity.

Melasma, for example, involves considerably more than melanocyte overactivity alone. Many lesions demonstrate increased vascularity, chronic low-level inflammation, oxidative stress, altered basement membrane integrity and elevated vascular signalling activity beneath the visible pigmentation itself. In other words, the tissue environment beneath the melasma may already be biologically unstable before treatment even begins.

That then raises an interesting mechanistic question.

If we deliberately create acute inflammation through procedures such as microneedling whilst simultaneously introducing complex extracellular signalling systems into an already inflamed, vascularly reactive or oxidatively stressed tissue environment, are we always certain the downstream biological interpretation remains coherent?

Perhaps in many patients it does. Perhaps in some patients it contributes positively towards regeneration and repair. However, biologically, one at least begins to wonder whether, under certain circumstances, we may also be amplifying inflammatory noise, melanocyte stress signalling, neurovascular instability or other downstream pathways we do not yet fully understand long term.

I am less convinced now than previously that the healthiest biological systems are necessarily the most stimulated systems. Often the healthiest systems appear to be the most coherent, the most well-regulated and the most capable of resolving stress appropriately once the required biological response has been achieved.

Perhaps the future of regenerative aesthetics will not simply involve increasing biological signalling, but improving the quality, interpretation and resolution of biological communication itself.

I suspect this exploration may eventually become a much larger body of work.